And some of those people who were given a severance because they didn't want to move to Boston are now getting calls about coming back if they position was allowed to remain in New Haven.
And some of those people who were given a severance because they didn't want to move to Boston are now getting calls about coming back if they position was allowed to remain in New Haven.
And some of those people who were given a severance because they didn't want to move to Boston are now getting calls about coming back if they position was allowed to remain in New Haven.
Soliris for MG is way overpriced, RA Pharma and John King will go to town on that. Genentech has a NMO drug that will be out next year that will be much easier to dose and a lot less expensive. Not sure I like this neuro expansion.